The US FDA said it revoked the emergency use authorization of the Janssen Covid-19 vaccine after the company requested the voluntary withdrawal of the EUA.
- Janssen informed the FDA that the last lots of the vaccine purchased by the US have expired
- No demand for new lots of the vaccine in the US
- No intention to update the strain composition of vaccine to address emerging variants
To view the source of this information, click
To contact the reporter on this story:
To contact the editor responsible for this story:
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.